InvestorsHub Logo
Followers 106
Posts 16521
Boards Moderated 0
Alias Born 06/24/2014

Re: None

Thursday, 01/25/2024 8:34:02 AM

Thursday, January 25, 2024 8:34:02 AM

Post# of 400
Processa Pharmaceuticals Announces Successful Completion of Phase 1b Safety Evaluation of NGC-Cap in Patients with Advanced Cancer Resulting in Recommended Phase 2 Doses
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PCSA News